Publications

Found 14 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Mice  [Clear All Filters]
2023
Martin B, Garman T, Laramee M, Wang A, Zhang X, Beck E, Wilson K, Klumpp-Thomas C, McKnight C, Xu X et al..  2023.  Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma. J Control Release. 357:580-590.
2021
Xiang C, Frietze KK, Bi Y, Li Y, Dal Pozzo V, Pal S, Alexander N, Baubet V, D'Acunto V, Mason CE et al..  2021.  RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing Neurons.. Mol Cell Biol. 41(7):e0052620.
2020
Schweitzer JS, Song B, Herrington TM, Park T-Y, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q et al..  2020.  Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.. N Engl J Med. 382(20):1926-1932.
2019
Tosi U, Kommidi H, Bellat V, Marnell CS, Guo H, Adeuyan O, Schweitzer ME, Chen N, Su T, Zhang G et al..  2019.  Real-Time, in Vivo Correlation of Molecular Structure with Drug Distribution in the Brain Striatum Following Convection Enhanced Delivery.. ACS Chem Neurosci. 10(5):2287-2298.
2018
Kelm-Nelson CA, Brauer AFL, Barth KJ, Lake JM, Sinnen MLK, Stehula FJ, Muslu C, Marongiu R, Kaplitt MG, Ciucci MR.  2018.  Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.. Brain Res. 1680:1-12.
Jannetti SA, Carlucci G, Carney B, Kossatz S, Shenker L, Carter LM, Salinas B, Brand C, Sadique A, Donabedian PL et al..  2018.  PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma.. J Nucl Med. 59(8):1225-1233.
2017
Kossatz S, Carney B, Schweitzer M, Carlucci G, Miloushev VZ, Maachani UB, Rajappa P, Keshari KR, Pisapia D, Weber WA et al..  2017.  Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.. Cancer Res. 77(8):2112-2123.
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K et al..  2017.  Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.. Clin Cancer Res. 23(12):3109-3119.
Wang M, Kommidi H, Tosi U, Guo H, Zhou Z, Schweitzer ME, Wu LY, Singh R, Hou S, Law B et al..  2017.  A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an [F]-Positron Emitting, Fluorescent Derivative of Dasatinib.. Mol Cancer Ther. 16(12):2902-2912.
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim J-H, Gorge E, Yanowitch R, Cope W, Vartanian E et al..  2017.  A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.. J Clin Invest. 127(5):1826-1838.
2016
Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, M Cenci A, Svenningsson P, Greengard P, Kaplitt MG.  2016.  Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.. Proc Natl Acad Sci U S A. 113(5):1423-8.
Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P.  2016.  p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.. Proc Natl Acad Sci U S A. 113(5):1429-34.
2010
Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B.  2010.  Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells.. Immunity. 33(6):905-16.
Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M et al..  2010.  Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med. 2(54):54ra76.